Skip to main content

National Institutes of Health — Portfolio, Page 9

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

491
Companies
$1.9B
Total invested
$4.9M
Avg. check
30
Industries
Health Care 18Biotechnology 14Medical 9Therapeutics 8Medical Device 5Artificial Intelligence (AI) 3+24 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 193–216 of 491
Spinogenix
June 2024

Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.

Biotechnology · San Diego$2.8M Venture - Series Unknown
Envisagenics
June 2024

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

Artificial Intelligence (AI) · Long Island City$25.0M Series B
Raydiant Oximetry
June 2024

Raydiant Oximetry is a medical device company focused on improving outcomes for mothers and babies during childbirth.

Biotechnology · San Ramon$7.5M Series A
SeLux Diagnostics
April 2024

SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

Biotechnology · Charlestown$48.0M Series D
Soterya
November 2023

AI-Driven Robotic Medical Technologies for Sleep Health

Artificial Intelligence (AI) · Everett$3.0M Seed
Cytonus Therapeutics
November 2023

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

Biotechnology · Carlsbad$11.7M Series A
Neurotype Inc.
September 2023

Medical Device, SaMD, Software, Neurotechnology, Biofeedback, Neurofeedback

Health Care · Minneapolis$329K Seed
Integrated BioTherapeutics
May 2023

Integrated BioTherapeutics focuses on the discovery of novel vaccines and therapeutics for emerging infectious diseases.

Biotechnology · Rockville$1.0M Venture - Series Unknown
SentiAR
April 2023

SentiAR is a digital health company that offers a holographic AR platform for intraprocedural clinical use.

3D Technology · St Louis$8.5M Series B
Thetis Pharmaceuticals
January 2025

Thetis Pharmaceuticals is a biopharmaceutical company.

Biotechnology · Ridgefield$9.0M Debt Financing
Coprata
January 2024

The digestive health platform of the future

Health Care · RoxboroPre-Seed
Novoron Bioscience
January 2026

Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.

Biopharma · San Diego$2.5M Grant
Amplo Biotechnology
January 2025

Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.

Biotechnology · La Jolla$2.9M Grant
Bleep
December 2021

Bleep provides best new CPAP solution on the market.

Health Care · Chapel Hill$1.7M Grant
Medcognetics
January 2023

Medcognetics is an IT company that provides cloud-based software-as-a-service leveraging artificial intelligence for the medical sector.

Information Technology · Dallas$750K Grant
Millennial Scientific
December 2022

Advanced material, and manufacturing company focused on Chromatography and allied products

Biotechnology · Stony Brook$1.5M Grant
Phenomix Sciences
December 2025

Phenomix Sciences is a biotechnology company that specializes in biotech, life science, metabolomics, and genomics.

Biotechnology · Rochester$2.5M Venture - Series Unknown
Explore Interactive
December 2021

Explore Interactive is a developer of augmented reality educational games

Augmented Reality · West Lafayette$1.0M Grant
Chemeleon
January 2023

Platform tech for ultra-rapid, instrument-free, point-of-care assays that provide lab-grade precision under one minute anywhere

Chemical · Brooklyn$1.7M Grant
Curi Bio
December 2025

Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.

Artificial Intelligence (AI) · Seattle$10.0M Series B
IVOS Medical
January 2025

IVOS Medical is a startup medical device specializing company in airway management.

Health Care · Dana Point$1.9M Grant
CODA Biotherapeutics
December 2021

CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.

Biotechnology · South San Francisco$28.0M Venture - Series Unknown
Prapela
December 2023

Prapela is a noninvasive stimuation therapy that improves breathing and oxygenation in newborns.

Children · BiddefordGrant
Trethera
December 2025

Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.

Biotechnology · Beverly Hills$2.7M Grant

Where National Institutes of Health invests

Health Care18
Biotechnology14
Medical9
Therapeutics8
Medical Device5
Artificial Intelligence (AI)3

About National Institutes of Health's portfolio

How many companies has National Institutes of Health invested in?▸

National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does National Institutes of Health invest in?▸

National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Medical Device. The firm invests across 30 different industry categories.

What is National Institutes of Health's largest investment?▸

Among tracked funding rounds, SeLux Diagnostics received $48.0M in a Series D round. National Institutes of Health's total known invested capital is $1.9B.

What is the average investment size for National Institutes of Health?▸

National Institutes of Health's average investment size is $4.9M across its portfolio of 491 companies.

What are National Institutes of Health's most recent investments?▸

Recent National Institutes of Health portfolio additions include Spinogenix, Envisagenics, Raydiant Oximetry, SeLux Diagnostics, Soterya. These companies were founded in 2020 or later.

Reach the founders behind these 491 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →